iiinova — where your digital self keeps evolving

Serge Alfandari @sergealf.bsky.social · 20/04/2025

@mrmrssmit.bsky.social salut. c'est dispo quand sur le google store?

Serge Alfandari @sergealf.bsky.social · 13/04/2025

Short versus long ATB treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials - CMI www.clinicalmicrobiologyandinfection.com/article/S119... On arrêterai pas les 10j pour les "à risque de complication" ?

clinicalmicrobiologyandinfection.com

Short versus long antibiotic treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials

To compile evidence on the durations of treatment for pyelonephritis or febrile complicated urinary tract infection (cUTI) in a living systematic review.

020

Reposted by Serge Alfandari

Société de Pathologie Infectieuse de Langue Française @spilf.bsky.social · 27/03/2025

Communiqué multi sociétés savantes SPILF, SF2H, SFM, SPLF, et SFGG Vaccination des personnes âgées hospitalisées ou institutionnalisées contre le VRS

infectiologie.com

054

Reposted by Serge Alfandari

Cryptococcose @cryptococcose.bsky.social · 03/01/2025

Les outils de communication pour le site de notification anonyme par SMS en cas d'IST sont dispo en téléchargement sur le site de la @sfls.bsky.social : - Affiche (à imprimer en grand ou format A5 pour des flyers) - carte de visite recto-verso santesex.sfls.fr/ressources/n... #STIskyFR #IDskyFR

Affiche du site www.notification-partenaire.fr en partenariat avec Sida Info Service et la SFLS

01513

Reposted by Serge Alfandari

Infectious Diseases Now @infdiseasesnow.bsky.social · 23/12/2024

[Publication] The article "Intravenous administration of antibiotics by prolonged and continuous infusion" is now available. www.sciencedirect.com/science/arti... #IDsky #Antibiotics #Administration #Guidelines

sciencedirect.com

Intravenous administration of antibiotics by prolonged and continuous infusion

032

Serge Alfandari @sergealf.bsky.social · 01/12/2024

Spot on, based on a single watchmen reference: blueskyroast.com/roast

030

Reposted by Serge Alfandari

Allison Bond @allisonrbond.bsky.social · 27/11/2024

Tenets of Infectious Diseases: 1. Source control, source control, source control 2. Stuff sticks to metal (and other material) 3. The drug has to get in to work (GI absorption, tissue penetration, presence of walled-off collection, etc.) 4. Antibiotics should not be anxiolytics

107618

Serge Alfandari @sergealf.bsky.social · 29/11/2024

Top ! En grande partie lié à l'élimination bilaire de la ceftriaxone. Utile sur les inf bilaires ou endoluminales, pas forcement pour les abcès intraabdo . #IDSkyFR

140

Serge Alfandari @sergealf.bsky.social · 24/11/2024

Un (premier ?) kit de démarrage sur infectiologie/maladies infectieuses pour les réfugiés de X. #IDSky, #IDSkyFr go.bsky.app/SsV6mPP

42812

Serge Alfandari @sergealf.bsky.social · 23/11/2024

State of the art reviews: Infections in immunocompromized hosts (in French)

010

Reposted by Serge Alfandari

Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 20/11/2024

🔥Everyone's favorite #shorterisbetter table is updated🔥 "BALANCE is now published, so the table is now updated! GNB bacteremia is now listed as Bacteremia(non S.aureus) Neary 5,000 patients have now been randomized to 1 vs. 2 Constantine Units for non S. aureus bacteremia " Dr.Spellberg #idsky

03212

Reposted by Serge Alfandari

José Molina @josemolinagb.bsky.social · 19/11/2024

#ShorterIsBetter in immunocompromised hosts? Short treatments are feasible in early responders without source control issues. A significant number of observational studies serve as proof-of-concept on the feasibility of short courses in selected patients (see ⚠️) #AMSsky #IDOnc #TxID #IDsky

A summary table on published observational studies on treatment duration of bloodstream infections in hematology patients with high-risk neutropenia.

References:
doi: 10.1007/s10096-024-04885-w
doi: 10.1111/tid.14085
doi: 10.1016/j.jinf.2021.10.017
doi: 10.1093/cid/ciad605
doi: 10.1093/ofid/ofaa246

A summary table on published observational studies on treatment duration of graft infections on solid-organ transplant recipients.

References:
doi: 10.1111/tid.13896
doi: 10.1111/tri.14144
doi: 10.1111/tid.13868
doi: 10.1111/tid.13518

24519

Reposted by Serge Alfandari

DocPaf @docpaf.bsky.social · 19/11/2024

Excellent bravo @spilf.bsky.social

132

Reposted by Serge Alfandari

Société de Pathologie Infectieuse de Langue Française @spilf.bsky.social · 17/11/2024

Infections cervicales profondes d’origine pharyngée: RCP de la SF ORL avec la SPILF #IDSky #AMSSky www.infectiologie.com/UserFiles/Fi... Et résumé info-antibio: www.infectiologie.com/UserFiles/Fi...

infectiologie.com

043

Reposted by Serge Alfandari

José Molina @josemolinagb.bsky.social · 17/11/2024

We lack oral options for most MDR-GNB among current or upcoming antibiotics, so ambulatory care for these patients will relay largely on #OPAT. The good news: most new agents are stable to be administered via infusion bags or elastomeric pumps 👉 www.mdpi.com/1999-4923/15... #AMSsky #IDsky

A table describing the stability of new betalactams at different temperatures. Source: https://www.mdpi.com/1999-4923/15/12/2705

A summary table with the route of administration of new and upcoming antibiotics against Gram-negative bacilli.
Source: https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/antibacterial-products-in-clinical-development-for-priority-pathogens

33014